Expected Moves

Actual outcome: Bull · $6.10 at outcome

Octave Specialty Group reported a narrower first-quarter loss and sharply higher adjusted earnings for Q1 2026. The strong performance was driven by rapid growth in its core insurance distribution business and significant contributions from its recent ArmadaCare acquisition. This positive financial surprise triggered a massive +43.36% surge in the stock price. [Market retrospective · Ultra-Short (1–5 days)] Missed anticipation: +43.4% from 2026-05-06 to 2026-06-01 (~9.6σ vs typical 1d vol). Target date 2026-05-11 reached; move through 2026-06-01 observed. Confidence 95%. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-02: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-02 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-03: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-03 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-04: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-04 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-05: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-05 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-08: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-08 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-09: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-09 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-10: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-10 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-11: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-11 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-12: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-12 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-15: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-15 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-16: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-16 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-17: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-17 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-18: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-18 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-06-19: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-06-19 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-07-06: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-07-06 observed. [Market retrospective · Ultra-Short (1–5 days)] Updated observation 2026-07-08: +43.4% from 2026-05-06 (~9.6σ). Target date 2026-05-11 reached; move through 2026-07-08 observed.

Actual outcome: Mixed · $4.59 at outcome

Octave Specialty Group's FY2025 10-K filing did not trigger an immediate material price reaction, with shares slipping 1.3% by the outcome date. However, sentiment improved in the following weeks as the company scheduled its Q1 2026 earnings release and annual stockholder meeting, helping drive the stock steadily higher to ultimately surpass the $5.40 bull target.